Cortecs expects turnaround in diagnostics next year
This article was originally published in Clinica
Cortecs predicts that its point-of-care diagnostics business will begin generating significant revenues in 2000. The drugs and diagnostics group has been undergoing a dramatic cost reduction programme under new management. The company has been selling off non-core assets, until such time as revenues from licensing and distribution partnering come onstream.